BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 9646645)

  • 1. Optimized sentinel node scintigraphy in breast cancer.
    Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
    Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node identification in breast cancer patients.
    Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
    Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
    Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
    J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
    Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
    Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoscintigraphy and gamma probe tracing in detecting breast cancer lymph node involvement: can they replace axillary lymph node dissection?
    Vaggelli L; Castagnoli A; Distante V; Orzalesi L; Cataliotti L; Cesco P
    Tumori; 2000; 86(4):322-4. PubMed ID: 11016716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
    Veronesi U; Paganelli G; Viale G; Galimberti V; Luini A; Zurrida S; Robertson C; Sacchini V; Veronesi P; Orvieto E; De Cicco C; Intra M; Tosi G; Scarpa D
    J Natl Cancer Inst; 1999 Feb; 91(4):368-73. PubMed ID: 10050871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative localization of the sentinel node in breast cancer: technical aspects of lymphoscintigraphic methods.
    De Cicco C; Chinol M; Paganelli G
    Semin Surg Oncol; 1998 Dec; 15(4):268-71. PubMed ID: 9829385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
    Allen B; Campbell I; Desai S; Dray M; Scarlet J
    N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
    Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
    Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
    Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
    J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.